The history of Viagra presents a complex picture for shareholders. While the initial launch generated substantial profits, the lapse of its exclusive rights opened the avenue to generic versions, dramatically reducing market share. This creates a specific challenge for firms banking on comparable blockbuster medications, suggesting that a Gambling

The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of generic competition , significantly diminishing its dominance. While some businesses may attempt to capitalize on male sexual dysfunction, the